{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:09:34Z","timestamp":1772071774317,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CPPS-WSU","award":["17A-2957-9838"],"award-info":[{"award-number":["17A-2957-9838"]}]},{"name":"CPPS-WSU","award":["R37CA233658"],"award-info":[{"award-number":["R37CA233658"]}]},{"name":"CPPS-WSU","award":["R01CA258634"],"award-info":[{"award-number":["R01CA258634"]}]},{"name":"NIH\/NCI","award":["17A-2957-9838"],"award-info":[{"award-number":["17A-2957-9838"]}]},{"name":"NIH\/NCI","award":["R37CA233658"],"award-info":[{"award-number":["R37CA233658"]}]},{"name":"NIH\/NCI","award":["R01CA258634"],"award-info":[{"award-number":["R01CA258634"]}]},{"name":"CPPS-WSU","award":["17A-2957-9838"],"award-info":[{"award-number":["17A-2957-9838"]}]},{"name":"CPPS-WSU","award":["R37CA233658"],"award-info":[{"award-number":["R37CA233658"]}]},{"name":"CPPS-WSU","award":["R01CA258634"],"award-info":[{"award-number":["R01CA258634"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Non-alcoholic steatohepatitis (NASH, also known as MASH) is a severe form of non-alcoholic fatty liver disease (NAFLD, also known as MASLD). Emerging data indicate that the progression of the disease to MASH is higher in postmenopausal women and that genetic susceptibility increases the risk of MASH-related cirrhosis. This study aimed to investigate the association between genetic polymorphisms in MASH and sexual dimorphism. We applied whole-exome sequencing (WES) to identify gene variants in 8 age-adjusted matched pairs of livers from both male and female patients. Sequencing alignment, variant calling, and annotation were performed using standard methods. Polymerase chain reaction (PCR) coupled with Sanger sequencing and immunoblot analysis were used to validate specific gene variants. cBioPortal and Gene Set Enrichment Analysis (GSEA) were used for actionable target analysis. We identified 148,881 gene variants, representing 57,121 and 50,150 variants in the female and male cohorts, respectively, of which 251 were highly significant and MASH sex-specific (p &lt; 0.0286). Polymorphisms in CAPN14, SLC37A3, BAZ1A, SRP54, MYH11, ABCC1, and RNFT1 were highly expressed in male liver samples. In female samples, Polymorphisms in RGSL1, SLC17A2, HFE, NLRC5, ACTN4, SBF1, and ALPK2 were identified. A heterozygous variant 1151G&gt;T located on 18q21.32 for ALPK2 (rs3809983) was validated by Sanger sequencing and expressed only in female samples. Immunoblot analysis confirmed that the protein level of \u03b2-catenin in female samples was 2-fold higher than normal, whereas ALPK2 expression was 0.5-fold lower than normal. No changes in the protein levels of either ALPK2 or \u03b2-catenin were observed in male samples. Our study suggests that the perturbation of canonical Wnt\/\u03b2-catenin signaling observed in postmenopausal women with MASH could be the result of polymorphisms in ALPK2.<\/jats:p>","DOI":"10.3390\/genes15030357","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T13:23:11Z","timestamp":1710336191000},"page":"357","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whole-Exome Sequencing (WES) Reveals Novel Sex-Specific Gene Variants in Non-Alcoholic Steatohepatitis (MASH)"],"prefix":"10.3390","volume":"15","author":[{"given":"Jing","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University Health Sciences, Spokane, WA 99202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang Jason","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University Health Sciences, Spokane, WA 99202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed S.","family":"Daoud","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University Health Sciences, Spokane, WA 99202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: What we are need in the future","volume":"38","author":"Araujo","year":"2017","journal-title":"Liver Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anndiagpath.2018.09.009","article-title":"Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging","volume":"37","author":"Koch","year":"2018","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but higher risk of progression vs men: A systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/hepr.13754","article-title":"Perturbation of Wnt\/\u03b2-catenin signaling and sexual dimorphism in non-alcoholic fatty liver disease","volume":"52","author":"Yeh","year":"2022","journal-title":"Hepatol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164117738442","article-title":"Interrelationship of canonical and non-canonical Wnt signaling pathways in chronic metabolic diseases","volume":"15","author":"Ackers","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_9","first-page":"2201","article-title":"Role and mechanisms of action of microRNA21 as regards the regulation of the Wnt\/\u03b2-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.3390\/nu7064453","article-title":"Low-density lipoprotein receptor-related 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis","volume":"7","author":"Go","year":"2015","journal-title":"Nutrients"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"665987","DOI":"10.3389\/fendo.2021.665987","article-title":"Gene-environmental interactions as metabolic drivers of nonalcoholic steatohepatitis","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/bioinformatics\/btz782","article-title":"An improved encoding of genetic variations in a Burrows-Wheeler transform","volume":"36","author":"Ohlebusch","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4939-8876-1_21","article-title":"Bioinformatics analysis of whole exome sequencing data","volume":"1881","author":"Ulintz","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation, and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat. Protoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"577623","DOI":"10.3389\/fgene.2021.577623","article-title":"Gene set enrichment analysis of interaction networks weighted by node centrality","volume":"12","author":"Zito","year":"2021","journal-title":"Front. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Davis, M.W., and Jorgensen, E.M. (2022). ApE, A Plasmid Editor: A freely available DNA manipulation and visualization program. Front. Bioinform., 2.","DOI":"10.3389\/fbinf.2022.818619"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: Allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12859-016-1197-0","article-title":"Var2GO: A web-based tool for gene variants selection","volume":"11","author":"Granata","year":"2016","journal-title":"BMC Bioinform."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.isci.2018.03.010","article-title":"ALPK2 promotes cardiogenesis in Zebrafish and human pluripotent stem cells","volume":"2","author":"Hofsteen","year":"2018","journal-title":"iScience"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contribution to NAFLD: Leveraging shared genetics to uncover system biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"The emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1038\/s41388-022-02367-x","article-title":"Identification of a novel Calpain-2-SRC feed-back loop as necessity for \u03b2-Catenin accumulation and signaling activation in hepatocellular carcinoma","volume":"41","author":"Ma","year":"2022","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2022.06.008","article-title":"Hydroxynonenal causes hepatocyte death by disrupting lysosomal integrity in non-alcoholic steatohepatitis","volume":"14","author":"Seike","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1162409","DOI":"10.3389\/fmolb.2023.1162409","article-title":"Novel insights into the progression and prognosis of the calpain family members in hepatocellular carcinoma: A comprehensive integrated analysis","volume":"10","author":"Dai","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molcel.2013.10.028","article-title":"The BRCA1\/BARD1-interacting protein OLA1 functions in centrosome regulation","volume":"53","author":"Matsuzawa","year":"2014","journal-title":"Mol. Cell."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12282-016-0709-0","article-title":"OLA1 gene sequencing in patients with BRCA1\/2 mutation negative suspected hereditary breast and ovarian cancer","volume":"24","author":"Takahashi","year":"2017","journal-title":"Breast Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.18632\/aging.102797","article-title":"Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21\/CDK2 in hepatocellular carcinoma","volume":"12","author":"Huang","year":"2020","journal-title":"Aging"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Meng, Z., Geng, X., Lin, X., Wang, Z., Chen, D., Liang, H., Zhu, Y., and Sui, Y. (2023). A prospective diagnostic and prognostic biomarker for hepatocellular carcinoma that functions in glucose metabolism regulation: Solute carrier family 37 member 3. Biochim. Biophys. Acta Mol. Basis Dis., 1868.","DOI":"10.1016\/j.bbadis.2023.166661"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.gim.2022.03.020","article-title":"Identification of autosomal recessive novel genes and retinal phenotypes in members of the solute carrier (SLC) superfamily","volume":"24","author":"Millo","year":"2022","journal-title":"Genet. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/bloodadvances.2019000709","article-title":"Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11","volume":"4","author":"Ishikawa","year":"2020","journal-title":"Blood Adv."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kadioglu, O., Saeed, M., Munder, M., Spuller, A., Greten, H.J., and Efferth, T. (2020). Identification of novel ABCC1 transporter mutations in tumor biopsies of cancer patients. Cells, 9.","DOI":"10.3390\/cells9020299"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ceca.2018.10.004","article-title":"Role of STIM1\/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease","volume":"76","author":"Michelucci","year":"2018","journal-title":"Cell Calcium"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/978-3-319-57732-6_30","article-title":"Metabolic disorders, and cancer: Hepatocyte store operated Ca2+ channels in nonalcoholic fatty liver disease","volume":"993","author":"Ali","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12860-019-0208-1","article-title":"Alternative splicing of the Wnt trafficking protein, Wntless and its effects on protein-protein interactions","volume":"20","author":"Petko","year":"2019","journal-title":"BMC Mol. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100744","DOI":"10.1016\/j.jhepr.2023.100744","article-title":"Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals","volume":"5","author":"Sun","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1038\/ncomms14121","article-title":"Exome and genome sequencing of nasopharynx cancer identifies NF-kB pathway activating mutations","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Bauer, S., Hezinger, L., Rexhepi, F., Ramanathan, S., and Kufer, T.A. (2023). NOD-like receptors-emerging links to obesity and associated morbidities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108595"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2015.05.023","article-title":"A mutation in the NLRC5 promoter limits NF-kB signaling after Salmonella Enteritidis infection in the spleen of young chickens","volume":"568","author":"Chang","year":"2015","journal-title":"Gene"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"McIntosh, A.T., Wei, R., Ahn, J., Aouizerat, B.E., Kassaye, S.G., Augenbraun, M.H., Price, J.C., French, A.L., Gange, S.J., and Anastos, K.M. (2021). A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV\/HCV coinfected women. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247277"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumor types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12935-020-01347-z","article-title":"Knockdown of ALPK2 inhibits the development and progression of ovarian cancer","volume":"20","author":"Zhu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"112029","DOI":"10.1016\/j.yexcr.2020.112029","article-title":"Knockdown of ALPK2 blocks development and progression of renal cell carcinoma","volume":"392","author":"Jiang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"De Lorenzo, S., Tovoli, F., Mazzotta, A., Vasuri, F., Edeline, J., Malvi, D., Boudjema, K., Renzulli, M., Jeddou, H., and D\u2019errico, A. (2020). Non-alcoholic steatohepatitis as a risk factor for interhepatic cholangiocarcinoma and its prognostic role. Cancers, 12.","DOI":"10.3390\/cancers12113182"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/apt.14910","article-title":"Increased risk of nonalcoholic fatty liver disease in patients with coelic disease on a gluten-free diet: Beyond traditional metabolic factor","volume":"48","author":"Tovoli","year":"2018","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/3\/357\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:12:55Z","timestamp":1760105575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/3\/357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["genes15030357"],"URL":"https:\/\/doi.org\/10.3390\/genes15030357","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]}}}